Cargando…

Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)

The clinical entity of adult T-cell leukemia (ATL) was established around 1977, and human T-cell leukemia virus type 1 (HTLV-I) was subsequently identified in 1980. In the 25 years since the discovery of HTLV-I, HTLV-I infection and its associated diseases have been extensively studied, and many of...

Descripción completa

Detalles Bibliográficos
Autor principal: Matsuoka, Masao
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1131926/
https://www.ncbi.nlm.nih.gov/pubmed/15854229
http://dx.doi.org/10.1186/1742-4690-2-27
_version_ 1782123961223479296
author Matsuoka, Masao
author_facet Matsuoka, Masao
author_sort Matsuoka, Masao
collection PubMed
description The clinical entity of adult T-cell leukemia (ATL) was established around 1977, and human T-cell leukemia virus type 1 (HTLV-I) was subsequently identified in 1980. In the 25 years since the discovery of HTLV-I, HTLV-I infection and its associated diseases have been extensively studied, and many of their aspects have been clarified. However, the detailed mechanism of leukemogenesis remains unsolved yet, and the prognosis of ATL patients still poor because of its resistance to chemotherapy and immunodeficiency. In this review, I highlight the recent progress and remaining enigmas in HTLV-I infection and its associated diseases, especially ATL.
format Text
id pubmed-1131926
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-11319262005-05-20 Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL) Matsuoka, Masao Retrovirology Review The clinical entity of adult T-cell leukemia (ATL) was established around 1977, and human T-cell leukemia virus type 1 (HTLV-I) was subsequently identified in 1980. In the 25 years since the discovery of HTLV-I, HTLV-I infection and its associated diseases have been extensively studied, and many of their aspects have been clarified. However, the detailed mechanism of leukemogenesis remains unsolved yet, and the prognosis of ATL patients still poor because of its resistance to chemotherapy and immunodeficiency. In this review, I highlight the recent progress and remaining enigmas in HTLV-I infection and its associated diseases, especially ATL. BioMed Central 2005-04-26 /pmc/articles/PMC1131926/ /pubmed/15854229 http://dx.doi.org/10.1186/1742-4690-2-27 Text en Copyright © 2005 Matsuoka; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Matsuoka, Masao
Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)
title Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)
title_full Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)
title_fullStr Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)
title_full_unstemmed Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)
title_short Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)
title_sort human t-cell leukemia virus type i (htlv-i) infection and the onset of adult t-cell leukemia (atl)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1131926/
https://www.ncbi.nlm.nih.gov/pubmed/15854229
http://dx.doi.org/10.1186/1742-4690-2-27
work_keys_str_mv AT matsuokamasao humantcellleukemiavirustypeihtlviinfectionandtheonsetofadulttcellleukemiaatl